AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $855,000 | -97.0% | 14,300 | -98.6% | 0.00% | -100.0% |
| Q3 2019 | $28,828,000 | +10.4% | 1,026,283 | +48.8% | 0.01% | +8.3% |
| Q2 2019 | $26,107,000 | +81.9% | 689,563 | +87.5% | 0.01% | +71.4% |
| Q1 2019 | $14,353,000 | -37.5% | 367,865 | -65.8% | 0.01% | -41.7% |
| Q4 2018 | $22,952,000 | +4.0% | 1,076,550 | +93.1% | 0.01% | +20.0% |
| Q3 2018 | $22,075,000 | +36.1% | 557,596 | +31.4% | 0.01% | +25.0% |
| Q2 2018 | $16,215,000 | +3402.2% | 424,375 | +2655.7% | 0.01% | – |
| Q1 2018 | $463,000 | -95.6% | 15,400 | -95.5% | 0.00% | -100.0% |
| Q4 2017 | $10,612,000 | +241.6% | 339,588 | +206.2% | 0.01% | +200.0% |
| Q3 2017 | $3,107,000 | +1485.2% | 110,921 | +981.3% | 0.00% | – |
| Q2 2017 | $196,000 | +6.5% | 10,258 | -5.2% | 0.00% | – |
| Q1 2017 | $184,000 | – | 10,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |